Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation

February 7, 2018

Responsive image

COPENHAGEN, Denmark, February 8, 2018 /PRNewswire/ —
Appoints Internationally Renowned Scientific Advisors
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announces…

Category: Precious Metals